Visiongain estimates that the global cell therapy technologies market will grow at a CAGR of 15% in the first half of the forecast period. In 2020, North America is estimated to hold 38% of the global cell therapy technologies market.
How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 201-page report you will receive 104 tables and 110 figures– all unavailable elsewhere.
The 201-page report provides clear detailed insight into the cell therapy technologies market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand-new report today you stay better informed and ready to act.
Report Scope
• Global Cell Therapy Technologies Market from 2020-2030
• Forecast of the Global Cell Therapy Technologies Market by Type of Product:
• Consumables
• Equipment: Cell Processing Equipment, Single Use Equipment, Other Equipment
• System & Software
• Forecast of the Global Cell Therapy Technologies by Process Type:
• Cell processing
• Cell preservation, distribution and handling
• Process monitoring and quality control
• Forecast of the Global Cell Therapy Technologies by Cell Type:
• Human cells: Stem cells, Differentiated cells
• Animal cells
• Forecast of the Global Cell Therapy Technologies by End User:
• Life Sciences and Research Companies
• Research Institutes
• This report provides individual revenue forecasts to 2030 for these national markets:
• The US
• Canada
• Mexico
• UK
• Germany
• France
• Italy
• Spain
• Japan
• China
• India
• South Korea
• Singapore
• Malaysia
• Russia
• Brazil
• Argentina
• UAE
• South Africa
• Nigeria
• Mexico
• Our study discusses the selected leading companies that are the major players in the respiratory inhalers market:
• GE Healthcare
• Lonza Group
• Merck KGaA
• Terumo Bct, Inc.
• Thermo Fisher Scientific, Inc.
• & Other Companies
• For the leading companies, we feature product portfolios, business segment breakdowns, recent developments & key expansion strategies etc.
• This report discusses factors that drive and restrain this market. As well as opportunities and challenges faced by this market.
• This report discusses the Porter’s Five Forces Analysis of the Cell Therapy Technologies Market.
• Key questions answered by this report:
• How is the Cell Therapy Technologies Market evolving?
• What is driving and restraining factors of the Cell Therapy Technologies Market?
• What are the market shares of each segment of the overall Cell Therapy Technologies Market in 2020?
• How will each Cell Therapy Technologies submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2030?
• How will the market shares for each Cell Therapy Technologies submarket develop from 2021 to 2030?
• What will be the main driver for the overall market from 2021 to 2030?
• Will leading national Cell Therapy Technologies Markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2030 and which geographical region will lead the market in 2030?
• Who are the leading players and what are their prospects over the forecast period?
• How will the industry evolve during the period between 2020 and 2030?
Visiongain’s study is intended for anyone requiring commercial analyses for the Cell Therapy Technologies Market. You find data, trends and predictions.
Buy our report today Global Cell Therapy Technologies Market : Consumables, Equipment, System & Software, Cell Processing, Cell Processing Equipment, Single Use Equipment, Cell Preservation, Distribution, Handling, Process Monitoring & Quality Control, Human Cells, Animal Cells, Life Sciences & Research Companies, Research Institutes.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1. Report Overview
1.1 Global Cell Therapy Technologies Market Overview
1.2 Market Definition and Methodology
1.3 Cell Therapy Technologies Market Report Structure
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.8 Frequently Asked Questions (FAQ)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2. Introduction to the Cell Therapy Technologies Market
2.1 What is Cell Therapy Technology?
2.2 Type of Cell Therapy Technologies
2.3 Key examples of Cell Therapy Technologies
3. Market Overview Cell Therapy Technologies Market
3.1 Porter’s Five Forces Analysis of Cell Therapy Technologies Market
3.1.1 Moderate supplier Bargaining Power
3.1.2 Low bargaining power of buyer
3.1.3 Low-level threats from substitute products
3.1.4 High-level threats from new entrants
3.1.5 High competition from industry players
3.2 Key Competitive Landscape for Cell Therapy Technologies
3.3 Global Cell Therapy Technologies Market Drivers
3.3.1 Emergence of Stem Cell Technology
3.3.2 Rise in Prevalence of Trauma Emergencies and Chronic Diseases
3.3.3 Advancement in Surgical Technologies and Monitoring Devices
3.3.4 Increase in the demand for single-use technologies in bio manufacturing
3.4 Global Cell Therapy Technologies Market Restraints
3.4.1 Operational Inefficiency
3.4.2 Stringent Regulatory Policies & Ethical Issues
3.4.3 High Cost of Treatments
3.5 Global Cell Therapy Technologies Market Opportunities
3.5.1 Opportunities in Stem Cell Applications
3.5.2 Core Competency in Emerging Economies
4. Cell Therapy technologies Market by Product Type 2020-2030
4.1 Cell Therapy Technologies Market for Consumables Forecasts 2020-2030
4.2 Cell Therapy Technologies Market for Equipment Forecasts 2020-2030
4.2.1 Equipment Market by Type 2020-2030
4.2.1.1 Cell Processing Equipment Market Forecasts 2020-2030
4.2.1.2 Single Use Equipment Market Forecasts 2020-2030
4.2.1.3 Other Equipment Market Forecasts 2020-2030
4.3 Cell Therapy Technologies Market for System & Software Forecasts 2020-2030
5. Cell Therapy Technologies Market by Process Type 2020-2030
5.1 Cell Therapy Technologies Market for Cell Processing Forecasts 2020-2030
5.2 Cell Therapy Technologies Market for Cell Preservation, Distribution, and Handling Forecasts 2020-2030
5.3 Cell Therapy Technologies Market for Process Monitoring and Quality Control Forecasts 2020-2030
6. Cell Therapy technologies Market by Cell Type 2020-2030
6.1 Cell Therapy Technologies Market for Human Cells Forecasts 2020-2030
6.1.1 Human Cells Market by Type 2020-2030
6.1.1.1 Human Cells Market for Stem Cells Forecasts 2020-2030
6.1.1.2 Human Cells Market for Differentiated Cells Forecasts 2020-2030
6.2 Cell Therapy Technologies Market for Animal Cells Forecasts 2020-2030
7. Cell Therapy Technologies Market by End User: Forecast & Analysis 2020-2030
7.1 Cell Therapy Technologies Market for Life Sciences and Research Company Forecasts 2020-2030
7.2 Cell Therapy Technologies Market for Research Institutes Forecasts 2020-2030
8. Regional Cell Therapy Technologies Market Forecasts 2020-2030
8.1 North American Cell Therapy Technologies Market Forecasts 2020-2030
8.1.1 North America Cell Therapy Technologies Market Forecasts by Country 2020-2030
8.1.1.1 U.S. Cell Therapy Technologies Market Forecasts 2020-2030
8.1.1.2 Canada Cell Therapy Technologies Market Forecasts 2020-2030
8.1.1.3 Mexico Cell Therapy Technologies Market Forecasts 2020-2030
8.1.2 North America Cell Therapy Technologies Market Forecasts by Product Type 2020-2030
8.1.3 North America Cell Therapy Technologies Market Forecasts by Process 2020-2030
8.1.4 North America Cell Therapy Technologies Market Forecasts by Cell Type 2020-2030
8.1.5 North America Cell Therapy Technologies Market Forecasts by End User 2020-2030
8.2 Europe Cell Therapy Technologies Market Forecasts 2021-2030
8.2.1 Europe Cell Therapy Technologies Market Forecasts by Country 2020-2030
8.2.1.1 Germany Cell Therapy Technologies Market Forecasts 2020-2030
8.2.1.2 UK Cell Therapy Technologies Market Forecasts 2020-2030
8.2.1.3 France Cell Therapy Technologies Market Forecasts 2020-2030
8.2.1.4 Russia Cell Therapy Technologies Market Forecasts 2020-2030
8.2.1.5 Spain Cell Therapy Technologies Market Forecasts 2020-2030
8.2.1.6 Italy Cell Therapy Technologies Market Forecasts 2020-2030
8.2.1.7 Rest of Europe Cell Therapy Technologies Market Forecasts 2020-2030
8.2.2 Europe Cell Therapy Technologies Market Forecasts by Product Type 2020-2030
8.2.3 Europe Cell Therapy Technologies Market Forecasts by Process 2020-2030
8.2.4 Europe Cell Therapy Technologies Market Forecasts by Cell Type 2020-2030
8.2.5 Europe Cell Therapy Technologies Market Forecasts by End User 2020-2030
8.3 Asia-Pacific Cell Therapy Technologies Market Forecasts 2020-2030
8.3.1 Asia Pacific Cell Therapy Technologies Market Forecasts by Country 2020-2030
8.3.1.1 China Cell Therapy Technologies Market Forecasts 2020-2030
8.3.1.2 Japan Cell Therapy Technologies Market Forecasts 2020-2030
8.3.1.3 India Cell Therapy Technologies Market Forecasts 2020-2030
8.3.1.4 South Korea Cell Therapy Technologies Market Forecasts 2020-2030
8.3.1.5 Singapore Cell Therapy Technologies Market Forecasts 2020-2030
8.3.1.6 Malaysia Cell Therapy Technologies Market Forecasts 2020-2030
8.3.1.7 Rest of Asia Pacific Cell Therapy Technologies Market Forecasts 2020-2030
8.3.2 Asia Pacific Cell Therapy Technologies Market Forecasts by Product Type 2020-2030
8.3.3 Asia Pacific Cell Therapy Technologies Market Forecasts by Process 2020-2030
8.3.4 Asia Pacific Cell Therapy Technologies Market Forecasts by Cell Type 2020-2030
8.3.5 Asia Pacific Cell Therapy Technologies Market Forecasts by End User 2020-2030
8.4 Rest of the World (RoW) Cell Therapy Technologies Market Forecasts 2020-2030
8.4.1 RoW Cell Therapy Technologies Market Forecasts by Country 2020-2030
8.4.1.1 Brazil Cell Therapy Technologies Market Forecasts 2020-2030
8.4.1.2 Argentina Cell Therapy Technologies Market Forecasts 2020-2030
8.4.1.3 UAE Cell Therapy Technologies Market Forecasts 2020-2030
8.4.1.4 Saudi Arabia Cell Therapy Technologies Market Forecasts 2020-2030
8.4.1.5 South Africa Cell Therapy Technologies Market Forecasts 2020-2030
8.4.1.6 Nigeria Cell Therapy Technologies Market Forecasts 2020-2030
8.4.1.7 Rest of ROW Cell Therapy Technologies Market Forecasts 2020-2030
8.4.2 RoW Cell Therapy Technologies Market Forecasts by Product Type 2020-2030
8.4.3 RoW Cell Therapy Technologies Market Forecasts by Process 2020-2030
8.4.4 RoW Cell Therapy Technologies Market Forecasts by Cell Type 2020-2030
8.4.5 RoW Cell Therapy Technologies Market Forecasts by End User 2020-2030
9. Leading Companies in the Cell Therapy Technologies Market
9.1 ThermoFisher Scientific Inc.
9.1.1 ThermoFisher Scientific Inc.: Business Overview
9.1.2 ThermoFisher Scientific Inc.: Product Portfolio
9.1.3 ThermoFisher Scientific Inc.: Financial Overview
9.1.4 ThermoFisher Scientific Inc.: Recent Developments
9.2 Sartorius Group
9.2.1 Sartorius Group: Business Overview
9.2.2 Sartorius Group: Product Portfolio
9.2.3 Sartorius Group: Financial Overview
9.2.4 Sartorius Group: Recent Developments
9.3 Merck KGaA
9.3.1 Merck KGaA: Business Overview
9.3.2 Merck KGaA: Product Portfolio
9.3.3 Merck KGaA: Financial Overview
9.3.4 Merck KGaA: Recent Developments
9.4 General Electric Company (GE Healthcare)
9.4.1 General Electric Company (GE Healthcare): Business Overview
9.4.2 GE Healthcare: Product Portfolio
9.4.3 General Electric Company: Financial Overview
9.4.4 General Electric Company: Recent Developments
9.5 Danaher Corporation
9.5.1 Danaher Corporation: Business Overview
9.5.2 Danaher Corporation: Product Portfolio
9.5.3 Danaher Corporation: Financial Overview
9.5.4 Danaher Corporation: Recent Developments
9.6 Terumo BCT, Inc.
9.6.1 Terumo BCT, Inc.: Business Overview
9.6.2 Terumo BCT, Inc.: Product Portfolio
9.6.3 Terumo BCT, Inc.: Financial Overview
9.6.4 Terumo BCT, Inc.: Recent Developments
9.7 Becton, Dickinson and Company
9.7.1 Becton, Dickinson and Company: Business Overview
9.7.2 Becton, Dickinson and Company: Product Portfolio
9.7.3 Becton, Dickinson and Company: Financial Overview
9.7.4 Becton, Dickinson and Company: Recent Developments
9.8 Lonza Group
9.8.1 Lonza Group: Business Overview
9.8.2 Lonza Group: Product Portfolio
9.8.3 Lonza Group: Financial Overview
9.8.4 Lonza Group: Recent Developments
9.9 Stemcell Technologies
9.9.1 Stemcell Technologies: Product Portfolio
9.9.2 Stemcell Technologies: Recent Developments
9.10 Miltenyi Biotec
9.10.1 Miltenyi Biotec: Product Portfolio
9.10.2 Miltenyi Biotec: Recent Developments
10. Conclusions
10.1 Current Leading Cell Therapy Technologies Market Segments
10.2 Leading Cell therapy technologies Companies
10.3 Leading Regional Markets
10.4 Emerging Cell Therapy Technologies Markets
11. Glossary
Associated Visiongain Reports
Visiongain Report Sales Order Form
Appendix A
About Visiongain
Appendix B
Visiongain report evaluation form
List of Tables
Table 4.1 Cell Therapy Technologies Market Forecast & Analysis 2020-2030, by Product Type, ($bn, AGR%, CAGR%) 2020-2030
Table 4.2 Cell Therapy Technologies Market for Consumables: Forecasts ($bn, AGR% CAGR%) 2020-2030
Table 4.3 Cell Therapy Technologies Market for Consumables, by Region, Forecast ($bn, AGR%, CAGR%) 2020-2030
Table 4.4 Cell Therapy Technologies Market for Equipment: Forecasts ($bn, AGR% CAGR%) 2020-2030
Table 4.5 Cell Therapy Technologies Market for Equipment, by Region, Forecast ($bn, AGR%, CAGR%) 2020-2030
Table 4.6 Equipment Market by Type Forecasts ($bn, AGR% CAGR%) 2020-2030
Table 4.7 Cell Processing Equipment Market Forecasts ($bn, AGR% CAGR%) 2020-2030
Table 4.8 Single Use Equipment Market Forecasts ($bn, AGR% CAGR%) 2020-2030
Table 4.9 Other Equipment Market Forecasts ($bn, AGR% CAGR%) 2020-2030
Table 4.10 Cell Therapy Technologies Market for System & Software: Forecasts ($bn, AGR% CAGR%) 2020-2030
Table 4.11 Cell Therapy Technologies Market for System & Software, by Region, Forecast ($bn, AGR%, CAGR%) 2020-2030
Table 5.1 Cell Therapy Technologies Market Forecast & Analysis 2020-2030, by Process Type, ($bn, AGR%, CAGR%) 2020-2030
Table 5.2 Cell Therapy Technologies Market for Cell Processing: Forecasts ($bn, AGR% CAGR%) 2020-2030
Table 5.3 Cell Therapy Technologies Market for Cell Processing, by Region, Forecast ($bn, AGR%, CAGR%) 2020-2030
Table 5.4 Cell Therapy Technologies Market for Cell Preservation, Distribution, and Handling: Forecasts ($bn, AGR% CAGR%) 2020-2030
Table 5.5 Cell Therapy Technologies Market for Cell Preservation, Distribution, and Handling, by Region, Forecast ($bn, AGR%, CAGR%) 2020-2030
Table 5.6 Cell Therapy Technologies Market for Process Monitoring and Quality Control: Forecasts ($bn, AGR% CAGR%) 2020-2030
Table 5.7 Cell Therapy Technologies Market for Process Monitoring and Quality Control, by Region, Forecast ($bn, AGR%, CAGR%) 2020-2030
Table 6.1 Cell Therapy Technologies Market Forecast & Analysis 2020-2030, by Cell Type, ($bn, AGR%, CAGR%) 2020-2030
Table 6.2 Cell Therapy Technologies Market for Human Cells: Forecasts ($bn, AGR% CAGR%) 2020-2030
Table 6.3 Cell Therapy Technologies Market for Human Cells, by Region, Forecast ($bn, AGR%, CAGR%) 2020-2030
Table 6.4 Human Cells Market by Type Forecasts ($bn, AGR% CAGR%) 2020-2030
Table 6.5 Human Cells Market for Stem Cells Forecasts ($bn, AGR% CAGR%) 2020-2030
Table 6.6 Human Cells Market for Differentiated Cells Forecasts ($bn, AGR% CAGR%) 2020-2030
Table 6.7 Cell Therapy Technologies Market for Animal Cells: Forecasts ($bn, AGR% CAGR%) 2020-2030
Table 6.8 Cell Therapy Technologies Market for Animal Cells, by Region, Forecast ($bn, AGR%, CAGR%) 2020-2030
Table 7.1 Cell Therapy Technologies Market Forecast & Analysis 2020-2030, by End User, ($bn, AGR%, CAGR%) 2020-2030
Table 7.2 Cell Therapy Technologies Market for Life Sciences and Research Companies: Forecasts ($bn, AGR% CAGR%) 2020-2030
Table 7.3 Cell Therapy Technologies Market for Life Sciences and Research Companies, by Region, Forecast ($bn, AGR%, CAGR%) 2020-2030
Table 7.4 Cell Therapy Technologies Market for Research institutes: Forecasts ($bn, AGR% CAGR%) 2020-2030
Table 7.5 Cell Therapy Technologies Market for Research Institutes, by Region, Forecast ($bn, AGR%, CAGR%) 2020-2030
Table 8.1 Regional Cell Therapy Technologies Market Forecasts ($bn, AGR% CAGR%) 2020-2030
Table 8.2 North America Cell Therapy Technologies Market, by Country ($bn, AGR%, CAGR%) 2020-2030
Table 8.3 U.S. Cell Therapy Technologies Market Forecasts ($bn, AGR% CAGR%) 2020-2030
Table 8.4 Canada Cell Therapy Technologies Market Forecasts ($bn, AGR% CAGR%) 2020-2030
Table 8.5 Mexico Cell Therapy Technologies Market Forecasts ($bn, AGR% CAGR%) 2020-2030
Table 8.6 North America Cell Therapy Technologies Market Forecasts, by Product Type ($bn, AGR% CAGR%) 2020-2030
Table 8.7 North America Cell Therapy Technologies Market Forecasts, by Process ($bn, AGR% CAGR%) 2020-2030
Table 8.8 North America Cell Therapy Technologies Market Forecasts, by Cell Type ($bn, AGR% CAGR%) 2020-2030
Table 8.9 North America Cell Therapy Technologies Market Forecasts, by End User ($bn, AGR% CAGR%) 2020-2030
Table 8.10 Europe Cell Therapy Technologies Market, by Country ($bn, AGR%, CAGR%) 2020-2030
Table 8.11 Germany Cell Therapy Technologies Market Forecasts ($bn, AGR% CAGR%) 2020-2030
Table 8.12 UK Cell Therapy Technologies Market Forecasts ($bn, AGR% CAGR%) 2020-2030
Table 8.13 France Cell Therapy Technologies Market Forecasts ($bn, AGR% CAGR%) 2020-2030
Table 8.14 Russia Cell Therapy Technologies Market Forecasts ($bn, AGR% CAGR%) 2020-2030
Table 8.15 Spain Cell Therapy Technologies Market Forecasts ($bn, AGR% CAGR%) 2020-2030
Table 8.16 Italy Cell Therapy Technologies Market Forecasts ($bn, AGR% CAGR%) 2020-2030
Table 8.17 Rest of Europe Cell Therapy Technologies Market Forecasts ($bn, AGR% CAGR%) 2020-2030
Table 8.18 Europe Cell Therapy Technologies Market Forecasts, by Product Type ($bn, AGR% CAGR%) 2020-2030
Table 8.19 Europe Cell Therapy Technologies Market Forecasts, by Process ($bn, AGR% CAGR%) 2020-2030
Table 8.20 Europe Cell Therapy Technologies Market Forecasts, by Cell Type ($bn, AGR% CAGR%) 2020-2030
Table 8.21 Europe Cell Therapy Technologies Market Forecasts, by End User ($bn, AGR% CAGR%) 2020-2030
Table 8.22 Asia Pacific Cell Therapy Technologies Market, by Country ($bn, AGR%, CAGR%) 2020-2030
Table 8.23 China Cell Therapy Technologies Market Forecasts ($bn, AGR% CAGR%) 2020-2030
Table 8.24 Japan Cell Therapy Technologies Market Forecasts ($bn, AGR% CAGR%) 2020-2030
Table 8.25 India Cell Therapy Technologies Market Forecasts ($bn, AGR% CAGR%) 2020-2030
Table 8.26 South Korea Cell Therapy Technologies Market Forecasts ($bn, AGR% CAGR%) 2020-2030
Table 8.27 Singapore Cell Therapy Technologies Market Forecasts ($bn, AGR% CAGR%) 2020-2030
Table 8.28 Malaysia Cell Therapy Technologies Market Forecasts ($bn, AGR% CAGR%) 2020-2030
Table 8.29 Rest of Asia Pacific Cell Therapy Technologies Market Forecasts ($bn, AGR% CAGR%) 2020-2030
Table 8.30 Asia Pacific Cell Therapy Technologies Market Forecasts, by Product Type ($bn, AGR% CAGR%) 2020-2030
Table 8.31 Asia Pacific Cell Therapy Technologies Market Forecasts, by Process ($bn, AGR% CAGR%) 2020-2030
Table 8.32 Asia Pacific Cell Therapy Technologies Market Forecasts, by Cell Type ($bn, AGR% CAGR%) 2020-2030
Table 8.33 Asia Pacific Cell Therapy Technologies Market Forecasts, by End User ($bn, AGR% CAGR%) 2020-2030
Table 8.34 Rest of the World (RoW) Cell Therapy Technologies Market, by Country ($bn, AGR%, CAGR%) 2020-2030
Table 8.35 Brazil Cell Therapy Technologies Market Forecasts ($bn, AGR% CAGR%) 2020-2030
Table 8.36 Argentina Cell Therapy Technologies Market Forecasts ($bn, AGR% CAGR%) 2020-2030
Table 8.37 UAE Cell Therapy Technologies Market Forecasts ($bn, AGR% CAGR%) 2020-2030
Table 8.38 Saudi Arabia Cell Therapy Technologies Market Forecasts ($bn, AGR% CAGR%) 2020-2030
Table 8.39 South Africa Cell Therapy Technologies Market Forecasts ($bn, AGR% CAGR%) 2020-2030
Table 8.40 Nigeria Cell Therapy Technologies Market Forecasts ($bn, AGR% CAGR%) 2020-2020
Table 8.41 Rest of ROW Cell Therapy Technologies Market Forecasts ($bn, AGR% CAGR%) 2020-2030
Table 8.42 RoW Cell Therapy Technologies Market Forecasts, by Product Type ($bn, AGR% CAGR%) 2020-2030
Table 8.43 RoW Cell Therapy Technologies Market Forecasts, by Process ($bn, AGR% CAGR%) 2020-2030
Table 8.44 RoW Cell Therapy Technologies Market Forecasts, by Cell Type ($bn, AGR% CAGR%) 2020-2030
Table 8.45 RoW Cell Therapy Technologies Market Forecasts, by End User ($bn, AGR% CAGR%) 2020-2030
Table 9.1 ThermoFisher Scientific Inc.: Business Overview
Table 9.2 ThermoFisher Scientific Inc.: Product Portfolio
Table 9.3 ThermoFisher Scientific Inc.: Recent Developments
Table 9.4 Sartorius Group: Business Overview
Table 9.5 Sartorius Group: Product Portfolio
Table 9.6 Sartorius Group: Recent Developments
Table 9.7 Merck KGaA: Business Overview
Table 9.8 Merck KGaA: Product Portfolio
Table 9.9 Merck KGaA: Recent Developments
Table 9.10 GE Healthcare: Business Overview
Table 9.11 GE Healthcare: Product Portfolio
Table 9.12 GE Healthcare: Recent Developments
Table 9.13 Danaher Corporation: Business Overview
Table 9.14 Danaher Corporation: Product Portfolio
Table 9.15 Danaher Corporation: Recent Developments
Table 9.16 Terumo BCT, Inc.: Business Overview
Table 9.17 Terumo BCT, Inc.: Product Portfolio
Table 9.18 Terumo BCT, Inc.: Recent Developments
Table 9.19 Becton, Dickinson and Company: Business Overview
Table 9.20 Becton, Dickinson and Company: Product Portfolio
Table 9.21 Becton, Dickinson and Company: Recent Developments
Table 9.22 Lonza Group: Business Overview
Table 9.23 Lonza Group: Product Portfolio
Table 9.24 Lonza Group: Recent Developments
Table 9.25 Stemcell Technologies: Product Portfolio
Table 9.26 Stemcell Technologies: Recent Developments
Table 9.27 Miltenyi Biotec: Product Portfolio
Table 9.28 Miltenyi Biotec: Recent Developments
List of Figures
Figure 1.1 Global Cell Therapy Technologies Market Segmentation Overview
Figure 3.2 Global Cell Therapy Technologies Market, Key Strategies share (%)
Figure 3.3 Global Cell Therapy Technologies Market: Leading company with number of strategies
Figure 4.1 Global Cell Therapy Technologies Market by Product Type, 2020 (% Share)
Figure 4.2 Cell Therapy Technologies Market Forecast & Analysis 2020-2030, by Product Type, ($bn, AGR%, CAGR%) 2020-2030
Figure 4.3 Cell Therapy Technologies Market for Consumables: Forecasts ($bn), 2020-2030
Figure 4.4 Cell Therapy Technologies Market for Consumables, by Region: Forecasts ($bn), 2020-2030
Figure 4.5 Cell Therapy Technologies Market for Equipment: Forecasts ($bn), 2020-2030
Figure 4.6 Cell Therapy Technologies Market for Equipment, by Region: Forecasts ($bn), 2020-2030
Figure 4.7 Equipment Market by type, 2020 (%share)
Figure 4.8 Cell Processing Equipment Market Forecasts ($bn), 2020-2030
Figure 4.9 Single Use Equipment Market Forecasts ($bn), 2020-2030
Figure 4.10 Other Equipment Market Forecasts ($bn), 2020-2030
Figure 4.11 Cell Therapy Technologies Market for System & Software: Forecasts ($bn), 2020-2030
Figure 4.12 Cell Therapy Technologies Market for System & Software, By Region: Forecasts ($bn), 2020-2030
Figure 5.1 Global Cell Therapy Technologies Market by Process Type, 2020, (% Share)
Figure 5.2 Cell Therapy Technologies Market Forecast & Analysis 2020-2030, by Process Type, ($bn, AGR%, CAGR%) 2020-2030
Figure 5.3 Cell Therapy Technologies Market for Cell Processing: Forecasts ($bn), 2020-2030
Figure 5.4 Cell Therapy Technologies Market for Cell Processing, by Region: Forecasts ($bn), 2020-2030
Figure 5.5 Cell Therapy Technologies Market for Cell Preservation, Distribution, and Handling: Forecasts ($bn), 2020-2030
Figure 5.6 Cell Therapy Technologies Market for Cell Preservation, Distribution, and Handling, by Region: Forecasts ($bn), 2020-2030
Figure 5.7 Cell Therapy Technologies Market for Process Monitoring and Quality Control: Forecasts ($bn), 2020-2030
Figure 5.8 Cell Therapy Technologies Market for Cell Preservation, Distribution, and Handling, By Region: Forecasts ($bn), 2020-2030
Figure 6.1 Global Cell Therapy Technologies Market by Cell Type, 2020, (% Share)
Figure 6.2 Cell Therapy Technologies Market Forecast & Analysis 2020-2030, by Cell Type, ($bn, AGR%, CAGR%) 2020-2030
Figure 6.3 Cell Therapy Technologies Market for Human Cells: Forecasts ($bn), 2020-2030
Figure 6.4 Cell Therapy Technologies Market for Human Cells, By Region: Forecasts ($bn), 2020-2030
Figure 6.5 Human Cells Market by type, 2020 (%share)
Figure 6.6 Human Cells Market for Stem Cells Forecasts ($bn), 2020-2030
Figure 6.7 Human Cells Market for Differentiated Cells Forecasts ($bn), 2020-2030
Figure 6.8 Cell Therapy Technologies Market for Animal Cells: Forecasts ($bn), 2020-2030
Figure 6.9 Cell Therapy Technologies Market for Animal Cells, by Region: Forecasts ($bn), 2020-2030
Figure 7.1 Global Cell Therapy Technologies Market by End User, 2020, (% Share)
Figure 7.2 Cell Therapy Technologies Market Forecast & Analysis 2020-2030, by End User, ($bn, AGR%, CAGR%) 2020-2030
Figure 7.3 Cell Therapy Technologies Market for Life Sciences and Research Companies: Forecasts ($bn), 2020-2030
Figure 7.4 Cell Therapy Technologies Market for Life Sciences and Research Companies, Market Share 2030
Figure 7.5 Cell Therapy Technologies Market for Life Sciences and Research Companies, By Region: Forecasts ($bn), 2020-2030
Figure 7.6 Cell Therapy Technologies Market for Research Institutes: Forecasts ($bn), 2020-2030
Figure 7.7 Cell Therapy Technologies Market for Research Institutes, by Region: Forecasts ($bn), 2020-2030
Figure 8.1 Regional Cell Therapy Technologies Markets Forecasts ($bn), 2020-2030
Figure 8.2 North America Cell Therapy Technologies Market Share Analysis, by Country (%), 2020
Figure 8.3 U.S. Cell Therapy Technologies Market Forecasts ($bn), 2020-2030
Figure 8.4 Canada Cell Therapy Technologies Market Forecasts ($bn), 2020-2030
Figure 8.5 Mexico Cell Therapy Technologies Market Forecasts ($bn), 2020-2030
Figure 8.6 North America Cell Therapy Technologies Market Revenue Analysis, by Product Type, 2020-2030
Figure 8.7 North America Cell Therapy Technologies Market Revenue Analysis, by Process, 2020-2030
Figure 8.8 North America Cell Therapy Technologies Market Revenue Analysis, by Cell Type, 2020-2030
Figure 8.9 North America Cell Therapy Technologies Market Revenue Analysis, by End User, 2020-2030
Figure 8.10 Europe Cell Therapy Technologies Market Share Analysis, by Country (%), 2020
Figure 8.11 Germany Cell Therapy Technologies Market Forecasts ($bn), 2020-2030
Figure 8.12 UK Cell Therapy Technologies Market Forecasts ($bn), 2020-2030
Figure 8.13 France Cell Therapy Technologies Market Forecasts ($bn), 2020-2030
Figure 8.14 Russia Cell Therapy Technologies Market Forecasts ($bn), 2020-2030
Figure 8.15 Spain Cell Therapy Technologies Market Forecasts ($bn), 2020-2030
Figure 8.16 Italy Cell Therapy Technologies Market Forecasts ($bn), 2020-2030
Figure 8.17 Rest of Europe Cell Therapy Technologies Market Forecasts ($bn), 2020-2030
Figure 8.18 Europe Cell Therapy Technologies Market Revenue Analysis, by Product Type, 2020-2030
Figure 8.19 Europe Cell Therapy Technologies Market Revenue Analysis, by Process, 2020-2030
Figure 8.20 Europe Cell Therapy Technologies Market Revenue Analysis, by Cell Type, 2020-2030
Figure 8.21 Europe Cell Therapy Technologies Market Revenue Analysis, by End User, 2020-2030
Figure 8.22 Asia Pacific Cell Therapy Technologies Market Share Analysis, by Country (%), 2020
Figure 8.23 China Cell Therapy Technologies Market Forecasts ($bn), 2020-2030
Figure 8.24 Japan Cell Therapy Technologies Market Forecasts ($bn), 2020-2030
Figure 8.25 India Cell Therapy Technologies Market Forecasts ($bn), 2020-2030
Figure 8.26 South Korea Cell Therapy Technologies Market Forecasts ($bn), 2020-2030
Figure 8.27 Singapore Cell Therapy Technologies Market Forecasts ($bn), 2020-2030
Figure 8.28 Malaysia Cell Therapy Technologies Market Forecasts ($bn), 2020-2030
Figure 8.29 Rest of Asia Pacific Cell Therapy Technologies Market Forecasts ($bn), 2020-2030
Figure 8.30 Asia Pacific Cell Therapy Technologies Market Revenue Analysis, by Product Type, 2020-2030
Figure 8.31 Asia Pacific Cell Therapy Technologies Market Revenue ($bn) Analysis, by Process, 2020-2030
Figure 8.32 Asia Pacific Cell Therapy Technologies Market Revenue Analysis, by Cell Type, 2020-2030
Figure 8.33 Asia Pacific Cell Therapy Technologies Market Revenue Analysis, by End User, 2020-2030
Figure 8.34 Rest of the World (RoW) Cell Therapy Technologies Market Share Analysis, by Country (%), 2020
Figure 8.35 Brazil Cell Therapy Technologies Market Forecasts ($bn), 2020-2030
Figure 8.36 Argentina Cell Therapy Technologies Market Forecasts ($bn), 2020-2030
Figure 8.37 UAE Cell Therapy Technologies Market Forecasts ($bn), 2020-2030
Figure 8.38 Saudi Arabia Cell Therapy Technologies Market Forecasts ($bn), 2020-2030
Figure 8.39 South Africa Cell Therapy Technologies Market Forecasts ($bn), 2020-2030
Figure 8.40 Nigeria Cell Therapy Technologies Market Forecasts ($bn), 2020-2030
Figure 8.41 Rest of ROW Cell Therapy Technologies Market Forecasts ($bn), 2020-2030
Figure 8.42 RoW Cell Therapy Technologies Market Revenue Analysis, by Product Type, 2020-2030
Figure 8.43 RoW Cell Therapy Technologies Market Revenue Analysis, by Process, 2020-2030
Figure 8.44 RoW Cell Therapy Technologies Market Revenue Analysis, by Cell Type, 2020-2030
Figure 8.45 RoW Cell Therapy Technologies Market Revenue Analysis, by End User, 2020-2030
Figure 9.1 ThermoFisher Scientific Inc. Annual Revenue 2014-2018 ($million)
Figure 9.2 ThermoFisher Scientific Inc.: Business Segment Revenue share 2018 (%)
Figure 9.3 ThermoFisher Scientific Inc.: Product Segment Revenue share 2018 (%)
Figure 9.4 ThermoFisher Scientific Inc.: Geography Segment Revenue share 2018 (%)
Figure 9.5 Sartorius Group: Annual Revenue 2014-2018 ($million)
Figure 9.6 Sartorius Group: Business Segment Revenue share 2018 (%)
Figure 9.7 Sartorius Group: Geography Segment Revenue share 2018 (%)
Figure 9.8 Merck KGaA: Annual Revenue 2014-2018 ($million)
Figure 9.9 Merck KGaA: Business Segment Revenue share 2018 (%)
Figure 9.10 Merck KGaA: Geography Segment Revenue share 2018 (%)
Figure 9.11 General Electric Company: Annual Revenue 2014-2018 ($million)
Figure 9.12 General Electric Company: Business Segment Revenue share 2018(%)
Figure 9.13 General Electric Company: Geography Segment Revenue share 2018 (%)
Figure 9.14 Danaher Corporation: Annual Revenue 2014-2018 ($million)
Figure 9.15 Danaher Corporation: Business Segment Revenue share 2018(%)
Figure 9.16 Danaher Corporation: Geography Segment Revenue share 2018 (%)
Figure 9.17 Terumo BCT, Inc.: Annual Revenue 2014-2018 ($million)
Figure 9.18 Terumo BCT, Inc.: Business Segment Revenue share 2018(%)
Figure 9.19 Terumo BCT, Inc.: Geography Segment Revenue share 2018 (%)
Figure 9.20 Becton, Dickinson and Company: Annual Revenue 2015-2019 ($million)
Figure 9.21 Becton, Dickinson and Company: Business Segment Revenue share 2019 (%)
Figure 9.22 Becton, Dickinson and Company: Geography Segment Revenue share 2019 (%)
Figure 9.23 Lonza Group: Annual Revenue 2014-2018 ($million)
Figure 9.24 Lonza Group: Business Segment Revenue share 2018 (%)
Figure 9.25 Lonza Group: Geography Segment Revenue share 2018 (%)
Figure 10.1 Cell Therapy Technologies Market Analysis, by Regions ($bn, AGR%), 2020-2030
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
